These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Fatty acids, eicosanoids, and hypolipidemic agents regulate gene expression through direct binding to peroxisome proliferator-activated receptors. Wahli W; Devchand PR; IJpenberg A; Desvergne B Adv Exp Med Biol; 1999; 447():199-209. PubMed ID: 10086196 [No Abstract] [Full Text] [Related]
5. PPAR-alpha: a key to the mechanism of hepatoprotection by clofibrate. Mehendale HM Toxicol Sci; 2000 Oct; 57(2):187-90. PubMed ID: 11006348 [TBL] [Abstract][Full Text] [Related]
6. Preparation of antiserum against rat delta6-desaturase and its use to evaluate the desaturase protein levels in rats treated with gemfibrozil, a ligand for peroxisome proliferator-activated receptor alpha. Shoji Y; Sanekata A; Sato M; Imaizumi K Biosci Biotechnol Biochem; 2003 May; 67(5):1177-8. PubMed ID: 12834305 [TBL] [Abstract][Full Text] [Related]
10. Murine models to investigate pharmacological compounds acting as ligands of PPARs in dyslipidemia and atherosclerosis. Tailleux A; Torpier G; Mezdour H; Fruchart JC; Staels B; Fiévet C Trends Pharmacol Sci; 2003 Oct; 24(10):530-4. PubMed ID: 14559405 [No Abstract] [Full Text] [Related]
11. Differences in the formation of PPARalpha-RXR/acoPPRE complexes between responsive and nonresponsive species upon fibrate administration. Rodríguez C; Noé V; Cabrero A; Ciudad CJ; Laguna JC Mol Pharmacol; 2000 Jul; 58(1):185-93. PubMed ID: 10860941 [TBL] [Abstract][Full Text] [Related]